| March 2011 | AIM-HIGH Baseline Paper
American Heart Journal, 2011 Mar; 161(3):538-43 |
| March 2011 | AIM-HIGH Design Paper: AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011 Mar;161(3):471-477.e2. Epub 2011 Feb 2. | | Dec 2011 | AIM-HIGH Primary Results Published in NEJM: AIM-HIGH Investigators. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy. N Engl J Medicine 2011 Dec 15;365(24):2255-67. Epub 2011 Nov 15 | | Dec 2011 | AIM-HIGH Primary Results Presented at AHA Scientific Sessions 2011 |
|
Funded by:
Support from:
Abbott Laboratories
|
